| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 9 |
| 1 | LEVONORGESTREL | 9 |
| 2 | CARBOPLATIN | 6 |
| 3 | PACLITAXEL | 5 |
| 4 | PACLITAXEL (AIBUMIN-BOUND) | 5 |
| 5 | ADALIMUMAB | 4 |
| 6 | ASPIRIN | 3 |
| 7 | ASPIRIN 325 MG | 3 |
| 8 | ASPIRIN 81 MG | 3 |
| 9 | CAPECITABINE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MEBENDAZOLE | 1 | 0.0013 |
| 1 | DINOPROSTONE | 1 | 0.0012 |
| 2 | LANTHANUM CARBONATE | 1 | 0.0002 |
| 3 | RAMUCIRUMAB | 1 | 0.0002 |
| 4 | APREPITANT | 1 | 0.0001 |
| 5 | MICONAZOLE NITRATE | 1 | 0.0001 |
| 6 | MEPERIDINE HYDROCHLORIDE | 1 | 0.0001 |
| 7 | MISOPROSTOL | 1 | 0.0001 |
| 8 | GOLIMUMAB | 1 | 0.0001 |
| 9 | FOSAPREPITANT DIMEGLUMINE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anthelmintic [EPC] | 1 | 0.0003 |
| 1 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 2 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 3 | Prostaglandin E1 Analog [EPC] | 1 | 0.0001 |
| 4 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 5 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 9 | 0.0000 |
| 6 | Microtubule Inhibitor [EPC] | 7 | 0.0000 |
| 7 | Androgen [EPC] | 1 | 0.0000 |
| 8 | Progestin [EPC] | 9 | 0.0000 |
| 9 | Platinum-based Drug [EPC] | 7 | 0.0000 |